Brad Kreger

Brad Kreger's Title

Brad Kreger currently holds the position of Chief Executive Officer (CEO). As the CEO, Kreger is responsible for overseeing the overall strategic direction, operational execution, and financial performance of the company. His leadership focuses on driving growth, enhancing customer satisfaction, and fostering innovation within the organization.

Brad Kreger's Previous Roles

Before becoming a CEO, Brad Kreger amassed valuable experience at notable companies such as Affymetrix, Thermo Fisher Scientific, and Fluidigm Corporation. At these organizations, he held various leadership roles, where he honed his skills in manufacturing, supply chain management, and strategic planning. His tenure at these companies provided him with a robust understanding of the life sciences and biotechnology industries.

Brad Kreger's Expertise

Brad Kreger's expertise lies in manufacturing and supply chain management across a diverse range of product categories. He has demonstrated his capability to lead large-scale production initiatives effectively, such as scaling PCR production to meet the urgent demands of COVID-19 testing. Additionally, his focus on operational efficiencies and infrastructure improvements has significantly enhanced customer experience and streamlined organizational execution.

Brad Kreger's Achievements

Among Brad Kreger's notable achievements is his leadership in increasing the production of mass cytometry technology at Fluidigm Corporation. This strategic initiative not only amplified the company's manufacturing capabilities but also positioned it as a leader in the field. Furthermore, Kreger played a pivotal role in rapidly scaling PCR production during the COVID-19 pandemic, ensuring that testing demands were met efficiently and effectively. His achievements reflect a strong commitment to innovation, operational excellence, and customer satisfaction.